29 research outputs found
Metabolic Imaging in Non-Alcoholic Fatty Liver Disease: Applications of Magnetic Resonance Spectroscopy
Non-alcoholic fatty liver disease (NAFLD) is poised to dominate the landscape of clinical hepatology in the 21st century. Its complex, interdependent aetiologies, non-linear disease progression and uncertain natural history have presented great challenges to the development of effective therapies. Progress will require an integrated approach to uncover molecular mediators, key pathogenic milestones and response to intervention at the metabolic level. The advent of precision imaging has yielded unprecedented insights into these processes. Quantitative imaging biomarkers such as magnetic resonance imaging (MRI), spectroscopy (MRS) and elastography (MRE) present robust, powerful tools with which to probe NAFLD metabolism and fibrogenesis non-invasively,in real time. Specific advantages of MRS include the ability to quantify static metabolite concentrations as well as dynamic substrate fluxin vivo. Thus, a vast range of key metabolic events inthe natural history of NAFLD can be explored using MRS. Here, we provide an overview of MRS for the clinician, as well as key pathways exploitable by MRS in vivo. Development, optimisation and validation of multinuclear MRS, in combination with other quantitative imaging techniques, may ultimately provide a robust, non-invasive alternative to liver biopsy for observational and longitudinal studies. Through enabling deeper insight into inflammatory and fibrogenic cascades, MRS may facilitate identification of novel therapeutic targets and clinically meaningful endpoints in NAFLD. Its widespread use in future could conceivably accelerate study design, data acquisition and availability of disease-modifying therapies at a population leve
Rapid and Progressive Regional Brain Atrophy in CLN6 Batten Disease Affected Sheep Measured with Longitudinal Magnetic Resonance Imaging.
Variant late-infantile Batten disease is a neuronal ceroid lipofuscinosis caused by mutations in CLN6. It is a recessive genetic lysosomal storage disease characterised by progressive neurodegeneration. It starts insidiously and leads to blindness, epilepsy and dementia in affected children. Sheep that are homozygous for a natural mutation in CLN6 have an ovine form of Batten disease Here, we used in vivo magnetic resonance imaging to track brain changes in 4 unaffected carriers and 6 affected Batten disease sheep. We scanned each sheep 4 times, between 17 and 22 months of age. Cortical atrophy in all sheep was pronounced at the baseline scan in all affected Batten disease sheep. Significant atrophy was also present in other brain regions (caudate, putamen and amygdala). Atrophy continued measurably in all of these regions during the study. Longitudinal MRI in sheep was sensitive enough to measure significant volume changes over the relatively short study period, even in the cortex, where nearly 40% of volume was already lost at the start of the study. Thus longitudinal MRI could be used to study the dynamics of progression of neurodegenerative changes in sheep models of Batten disease, as well as to assess therapeutic efficacy
Design of a Skipper CCD Focal Plane for the SOAR Integral Field Spectrograph
We present the development of a Skipper Charge-Coupled Device (CCD) focal
plane prototype for the SOAR Telescope Integral Field Spectrograph (SIFS). This
mosaic focal plane consists of four 6k 1k, 15 m pixel Skipper
CCDs mounted inside a vacuum dewar. We describe the process of packaging the
CCDs so that they can be easily tested, transported, and installed in a mosaic
focal plane. We characterize the performance of m thick,
fully-depleted engineering-grade Skipper CCDs in preparation for performing
similar characterization tests on science-grade Skipper CCDs which will be
thinned to 250m and backside processed with an antireflective coating. We
achieve a single-sample readout noise of for the best
performing amplifiers and sub-electron resolution (photon counting
capabilities) with readout noise from 800
measurements of the charge in each pixel. We describe the design and
construction of the Skipper CCD focal plane and provide details about the
synchronized readout electronics system that will be implemented to
simultaneously read 16 amplifiers from the four Skipper CCDs (4-amplifiers per
detector). Finally, we outline future plans for laboratory testing,
installation, commissioning, and science verification of our Skipper CCD focal
plane
Liver glycogen stores via 13C magnetic resonance spectroscopy in healthy children: randomized, controlled study
BackgroundOwing to its role in glucose homeostasis, liver glycogen concentration ([LGly]) can be a marker of altered metabolism seen in disorders which impact health of children. However, there is a paucity of normative data for this measure in children to allow comparison with patients, and time-course assessment of [LGly] in response to feeding has not been reported. 13C-magnetic resonance spectroscopy (13C-MRS) is used extensively in research to non-invasively assess liver metabolites in adult health and disease, but similar measurements in children are lacking.ObjectiveThe main objectives were to quantify the depletion of [LGly] after overnight fasting, and the subsequent response to feeding.DesignIn a randomized, open-label, incomplete block design study, healthy, normal-weight children (8-12y) attended 2 evening visits, each separated by â„5 days and directly followed by a morning visit. An individually tailored, standardized meal was consumed 3-hours prior to evening assessments. Participants then remained fasted until the morning visit. [LGly] was assessed once in the fed (20:00hrs) and fasted state (08:00hrs) using 13C-MRS. After the 8:00hrs assessment, 200ml of a mixed-macronutrient drink containing 15.5g (402kJ) or 31g carbohydrate (804kJ), or water only, was consumed, with 13C-MRS measurements then performed hourly for 4h. Each child was randomized to 2 of 3 drink options across the 2 mornings. Data are expressed as mean (SD).ResultsTwenty-four children (13F:11M) completed the study (9.9(1.1)y, BMI percentile 45.7(25.9)). [LGly] decreased from 377.9(141.3) to 277.3(107.4) mmol·l-1 overnight; depletion rate 0.14(0.15) mmol·l-1·min-1. Incremental responses of [LGly] to test drinks differed (P<0.001), with incremental net AUC of [LGly] over 4h (i.netAUC240min) being higher for 15.5g (-67.1(205.8) mmol·l-1·240min; P<0.01) and 31g carbohydrate (101.6(180.9) mmol·l-1·240min; P<0.005) compared to water (-253.1(231.2) mmol·l-1·240min).ConclusionAfter overnight fasting, [LGly] decreased by 22.9(25.1)%, and [LGly] i.netAUC240min was higher after subsequent consumption of 15.5g and 31g carbohydrate, compared to water.Clinical Trial Registry number: NCT04278209 (www.clinicaltrials.gov
Prime Focus Spectrograph - Subaru's future -
The Prime Focus Spectrograph (PFS) of the Subaru Measurement of Images and
Redshifts (SuMIRe) project has been endorsed by Japanese community as one of
the main future instruments of the Subaru 8.2-meter telescope at Mauna Kea,
Hawaii. This optical/near-infrared multi-fiber spectrograph targets cosmology
with galaxy surveys, Galactic archaeology, and studies of galaxy/AGN evolution.
Taking advantage of Subaru's wide field of view, which is further extended with
the recently completed Wide Field Corrector, PFS will enable us to carry out
multi-fiber spectroscopy of 2400 targets within 1.3 degree diameter. A
microlens is attached at each fiber entrance for F-ratio transformation into a
larger one so that difficulties of spectrograph design are eased. Fibers are
accurately placed onto target positions by positioners, each of which consists
of two stages of piezo-electric rotary motors, through iterations by using
back-illuminated fiber position measurements with a wide-field metrology
camera. Fibers then carry light to a set of four identical fast-Schmidt
spectrographs with three color arms each: the wavelength ranges from 0.38
{\mu}m to 1.3 {\mu}m will be simultaneously observed with an average resolving
power of 3000. Before and during the era of extremely large telescopes, PFS
will provide the unique capability of obtaining spectra of 2400
cosmological/astrophysical targets simultaneously with an 8-10 meter class
telescope. The PFS collaboration, led by IPMU, consists of USP/LNA in Brazil,
Caltech/JPL, Princeton, & JHU in USA, LAM in France, ASIAA in Taiwan, and
NAOJ/Subaru.Comment: 13 pages, 11 figures, submitted to "Ground-based and Airborne
Instrumentation for Astronomy IV, Ian S. McLean, Suzanne K. Ramsay, Hideki
Takami, Editors, Proc. SPIE 8446 (2012)
Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunctionâassociated steatotic liver disease but is not altered by 6 weeks of exercise training
Aims: To examine the impact of impaired glycaemic regulation (IGR) and exercise training on hepatic lipid composition in men with metabolic dysfunctionâassociated steatotic liver disease (MASLD). Materials and Methods: In Part A (crossâsectional design), 40 men with MASLD (liver proton density fat fraction [PDFF] â„5.56%) were recruited to one of two groups: (1) normal glycaemic regulation (NGR) group (glycated haemoglobin [HbA1c] < 42 mmolâmolâ1 [<6.0%]; n = 14) or (2) IGR group (HbA1c â„ 42 mmolâmolâ1 [â„6.0%]; n = 26). In Part B (randomized controlled trial design), participants in the IGR group were randomized to one of two 6âweek interventions: (1) exercise training (EX; 70%â75% maximum heart rate; four sessions/week; n = 13) or (2) nonâexercise control (CON; n = 13). Saturated (SI; primary outcome), unsaturated (UI) and polyunsaturated (PUI) hepatic lipid indices were determined using proton magnetic resonance spectroscopy. Additional secondary outcomes included liver PDFF, HbA1c, fasting plasma glucose (FPG), homeostatic model assessment of insulin resistance (HOMAâIR), peak oxygen uptake (VO2 peak), and plasma cytokeratinâ18 (CK18) M65, among others. Results: In Part A, hepatic SI was higher and hepatic UI was lower in the IGR versus the NGR group (p = 0.038), and this hepatic lipid profile was associated with higher HbA1c levels, FPG levels, HOMAâIR and plasma CK18 M65 levels (r s â„0.320). In Part B, hepatic lipid composition and liver PDFF were unchanged after EX versus CON (p â„ 0.257), while FPG was reduced and VO2 peak was increased (p †0.030). ÎVO2 peak was inversely associated with Îhepatic SI (r = â0.433) and positively associated with Îhepatic UI and Îhepatic PUI (r â„ 0.433). Conclusions: Impaired glycaemic regulation in MASLD is characterized by greater hepatic lipid saturation; however, this composition is not altered by 6 weeks of moderateâintensity exercise training
Effects of sprint interval training on ectopic lipids and tissue-specific insulin sensitivity in men with non-alcoholic fatty liver disease
Purpose: This study examined the feasibility of sprint interval exercise training (SIT) for men with non-alcoholic fatty liver disease (NAFLD) and its effects on intrahepatic triglyceride (IHTG), insulin sensitivity (hepatic and peripheral), visceral (VAT) and subcutaneous adipose tissue (ScAT).
Methods: Nine men with NAFLD (age 41 ± 8 years; BMI 31.7 ± 3.1 kg mâ2; IHTG 15.6 ± 8.3%) were assessed at: (1) baseline (2) after a control phase of no intervention (pre-training) and (3) after 6 weeks of SIT (4â6 maximal 30 s cycling intervals, three times per week). IHTG, VAT and ScAT were measured using magnetic resonance spectroscopy or imaging and insulin sensitivity was assessed via dual-step hyperinsulinaemic-euglycaemic clamp with [6,6-D2] glucose tracer.
Results: Participants adhered to SIT, completing â„ 96.7% of prescribed intervals. SIT increased peak oxygen uptake [ V O2peak: + 13.6% (95% CI 8.8â18.2%)] and elicited a relative reduction in IHTG [â 12.4% (â 31.6 to 6.7%)] and VAT [â 16.9% (â 24.4 to â 9.4%); n = 8], with no change in body weight or ScAT. Peripheral insulin sensitivity increased throughout the study (n = 8; significant main effect of phase) but changes from pre- to post-training were highly variable (range â 18.5 to + 58.7%) and not significant (P = 0.09), despite a moderate effect size (g* = 0.63). Hepatic insulin sensitivity was not influenced by SIT.
Conclusions: SIT is feasible for men with NAFLD in a controlled laboratory setting and is able to reduce IHTG and VAT in the absence of weight loss
CHR-2797: An Antiproliferative Aminopeptidase Inhibitor that Leads to Amino Acid Deprivation in Human Leukemic Cells
BLOOM: A 176B-Parameter Open-Access Multilingual Language Model
Large language models (LLMs) have been shown to be able to perform new tasks
based on a few demonstrations or natural language instructions. While these
capabilities have led to widespread adoption, most LLMs are developed by
resource-rich organizations and are frequently kept from the public. As a step
towards democratizing this powerful technology, we present BLOOM, a
176B-parameter open-access language model designed and built thanks to a
collaboration of hundreds of researchers. BLOOM is a decoder-only Transformer
language model that was trained on the ROOTS corpus, a dataset comprising
hundreds of sources in 46 natural and 13 programming languages (59 in total).
We find that BLOOM achieves competitive performance on a wide variety of
benchmarks, with stronger results after undergoing multitask prompted
finetuning. To facilitate future research and applications using LLMs, we
publicly release our models and code under the Responsible AI License
The role of hepatic lipid composition in obesity-related metabolic disease
Obesity is a primary antecedent to non-alcoholic fatty liver disease whose cardinal feature is excessive hepatic lipid accumulation. Although total hepatic lipid content closely associates with hepatic and systemic metabolic dysfunction, accumulating evidence suggests that the composition of hepatic lipids may be more discriminatory. This review summarises cross-sectional human studies using liver biopsy/lipidomics and proton magnetic resonance spectroscopy to characterise hepatic lipid composition in people with obesity and related metabolic disease. A comprehensive literature search identified 26 relevant studies published up to 31st March 2021 which were included in the review. The available evidence provides a consistent picture showing that people with hepatic steatosis possess elevated saturated and/or monounsaturated hepatic lipids and a reduced proportion of polyunsaturated hepatic lipids. This altered hepatic lipid profile associates more directly with metabolic derangements, such as insulin resistance, and may be exacerbated in non-alcoholic steatohepatitis. Further evidence from lipidomic studies suggests that these deleterious changes may be related to defects in lipid desaturation and elongation, and an augmentation of the de novo lipogenic pathway. These observations are consistent with mechanistic studies implicating saturated fatty acids and associated bioactive lipid intermediates (ceramides, lysophosphatidylcholines and diacylglycerol) in the development of hepatic lipotoxicity and wider metabolic dysfunction, whilst monounsaturated fatty acids and polyunsaturated fatty acids may exhibit a protective role. Future studies are needed to prospectively determine the relevance of hepatic lipid composition for hepatic and non-hepatic morbidity and mortality; and to further evaluate the impact of therapeutic interventions such as pharmacotherapy and lifestyle intervention